UBS lowered the firm’s price target on Progressive (PGR) to $280 from $291 and keeps a Neutral rating on the shares. P&C Insurance stocks under coverage were down 4% in 2Q25, on average, reflecting less favorable fundamentals and a shift from defensive stocks to more economically sensitive stocks, the analyst tells investors in a research note. UBS favors Personal lines insurers into 2Q25 results where margins remain attractive.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PGR:
- Is PGR a Buy, Before Earnings?
- Progressive price target raised to $337 from $333 at BofA
- Progressive’s Undervalued Stock and Growth Potential: A Buy Recommendation by Joshua Shanker
- Progressive price target lowered to $287 from $297 at Barclays
- Hold Rating for Progressive Amidst Competitive Pressures and Valuation Concerns